Highmark Medicare Services (HMS) confirmed with remote monitoring service provider CardioNet that the reduced reimbursement rate for mobile cardiovascular technology will become effective today, ...

If the folks behind CardioNet had been hooked to its own devices recently, said devices might well have seen some big spikes in heart rates as news arrived that UnitedHealthcare Insurance would ...

Wireless health monitoring company CardioNet named Joseph Capper president and CEO this week, effective immediately. Capper was formerly president and CEO of diabetes care company Home Diagnostics, ...

NEW ORLEANS--(BUSINESS WIRE)--CTIA Wireless – Telit Wireless Solutions (AIM: TCM), a global leader in machine-to-machine (M2M) wireless technology, today announced its CC864-DUAL cellular module will ...

When it comes to diagnosing and treating arrhythmias, time is of the essence. Delays can cause anxiety for patients, or, on the extreme end, death. Twelve-year-old device firm CardioNet Inc.

NEW ORLEANS--(BUSINESS WIRE)--San Diego-based CardioNet, Inc., the leading provider of wireless mobile cardiac outpatient monitoring solutions, announced today that it has closed on $110 million in ...

BANGALORE, July 13 (Reuters) - Shares of CardioNet Inc fell 36 percent Monday, a day after the company withdrew its 2009 outlook as Pennsylvania Medicare carrier Highmark cut the reimbursement rate ...

(Reuters) - Heart monitoring services provider CardioNet Inc said it would buy privately owned Cardiocore Lab Inc for $23.5 million to expand into laboratory services and reduce its reimbursement ...

CardioNet asserted its patent directed to cardiac monitoring against InfoBionic in the U.S. District Court for the District of Massachusetts. The defendant moved to dismiss the complaint, arguing that ...

BioTelemetry and its subsidiary CardioNet, both based in Pennsylvania, have agreed to pay almost $44.9 million to resolve allegations that it knowingly submitted claims to Medicare and other federal ...

Medical technology company BioTelemetry and its heart rate monitoring subsidiary CardioNet agreed to pay more than $44.8 million to settle allegations they violated U.S. federal health laws by ...